Tatva Chintan Pharma Chem Limited
Nippon India Mutual Fund decreased its stake in Tatva Chintan Pharma Chem Limited from 2.29% to 2.21%, selling 20,000 shares.
A specialty chemicals manufacturer producing structure directing agents, phase transfer catalysts, electrolyte salts for batteries, and pharmaceutical and agrochemical intermediates. Incorporated in 1996, the company operates across multiple industrial verticals including pharmaceuticals, agrochemicals, and battery technology sectors. Its distinctive capabilities center on manufacturing high-purity specialty chemicals that enable production processes in these demanding industries, serving both domestic and international markets with customized chemical solutions.
India's fifth-largest AMC with over Rs 6 lakh crore in AUM, backed by Japan's Nippon Life Insurance which holds majority stake. Formerly Reliance MF, rebranded in 2019 after Nippon's acquisition. Sailesh Raj Bhan has run the equity book for over two decades and is one of India's most experienced active managers. Known for sector rotational calls and a deep research bench.